Rapid Micro Biosystems (RPID) Total Non-Current Liabilities (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Total Non-Current Liabilities of $41.8 million in Q1 2026, up 1.45% quarter-over-quarter from $41.2 million in Q4 2025, and up 113.11% year-over-year from $19.6 million in Q1 2025.
Rapid Micro Biosystems' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $41.8 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 113.11% year-over-year to $41.8 million; the TTM figure through Mar 2026 stood at $41.8 million (up 113.11% YoY), while the FY2025 annual figure was $41.2 million, up 80.78% from the prior year.
- Total Non-Current Liabilities came in at $41.8 million for Q1 2026 at Rapid Micro Biosystems, up from $41.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $41.8 million in Q1 2026 to a low of $19.6 million in Q1 2025.
- A 5-year average of $25.4 million and a median of $22.2 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities tumbled 83.58% in 2022 and jumped 113.11% in 2026, its largest moves.
- Rapid Micro Biosystems' Total Non-Current Liabilities stood at $26.3 million in 2022, then slipped by 4.01% to $25.2 million in 2023, then slipped by 9.46% to $22.8 million in 2024, then soared by 80.78% to $41.2 million in 2025, then climbed by 1.45% to $41.8 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $41.8 million, $41.2 million, and $39.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | 41.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.85 Mn |
| Dec 31, 2025 | 41.25 Mn |
| Sep 30, 2025 | 39.72 Mn |
| Jun 30, 2025 | 20.73 Mn |
| Mar 31, 2025 | 19.64 Mn |
| Dec 31, 2024 | 22.52 Mn |
| Sep 30, 2024 | 21.18 Mn |
| Jun 30, 2024 | 22.22 Mn |
| Mar 31, 2024 | 21.52 Mn |
| Dec 31, 2023 | 25.20 Mn |
| Sep 30, 2023 | 22.12 Mn |
| Jun 30, 2023 | 21.07 Mn |
| Mar 31, 2023 | 20.60 Mn |
| Dec 31, 2022 | 26.25 Mn |
| Sep 30, 2022 | 22.68 Mn |
| Jun 30, 2022 | 20.48 Mn |
| Mar 31, 2022 | 22.25 Mn |
| Dec 31, 2021 | 18.98 Mn |
| Sep 30, 2021 | 18.45 Mn |
| Jun 30, 2021 | 42.33 Mn |
| Mar 31, 2021 | 135.48 Mn |
| Dec 31, 2020 | 41.06 Mn |
| Sep 30, 2020 | 110.32 Mn |
| Jun 30, 2020 | 99.73 Mn |